Vandenburg M J
Br J Clin Pharmacol. 1982 Nov;14(5):733-7. doi: 10.1111/j.1365-2125.1982.tb04965.x.
1 The effects of oxprenolol and propranolol on peripheral blood flow were compared in patients with mild and moderate essential hypertension. 2 In an acute double-blind crossover study in which eight patients participated there was a significant reduction in resting forearm blood flow (RFBF) 2 h after 80 mg propranolol (mean +/- s.e. mean) (-0.87 +/- 0.13 microliter min-1 100 g-1) and after 80 mg oxprenolol (-0.30 +/- 0.12) but not after placebo. This reduction was significantly greater after propranolol (P = 0.022). 3 Seven patients continued into a double-blind crossover study comparing the above dose of the two drugs twice a day. On both the beta-adrenoceptor blockers there was a significant reduction in blood pressure after 2 weeks of treatment and also a significant reduction in RFBF. 4 After 6 weeks treatment with propranolol the reduction in RFBF persisted and was significantly less (P = 0.04) than after 6 weeks treatment of oxprenolol, at which time RFBF was back to control. 5 There were no consistent changes in skin temperature. 6 Neither propranolol nor oxprenolol should be used in patients with severe peripheral vascular disease. 7 If beta-adrenoceptor blockade is necessary in patients with mild peripheral vascular disease oxprenolol should be used in preference to propranolol but should be prescribed with caution.
比较了氧烯洛尔和普萘洛尔对轻度和中度原发性高血压患者外周血流的影响。
在一项有8名患者参与的急性双盲交叉研究中,80毫克普萘洛尔(均值±标准误均值)给药2小时后静息前臂血流量(RFBF)显著降低(-0.87±0.13微升·分钟-1·100克-1),80毫克氧烯洛尔给药后也显著降低(-0.30±0.12),但安慰剂给药后无此现象。普萘洛尔给药后的降低幅度显著更大(P = 0.022)。
7名患者继续参与一项双盲交叉研究,比较上述剂量的两种药物每日两次给药的情况。两种β肾上腺素受体阻滞剂在治疗2周后血压均显著降低,RFBF也显著降低。
普萘洛尔治疗6周后,RFBF的降低持续存在,且显著低于氧烯洛尔治疗6周后的降低幅度(P = 0.04),此时氧烯洛尔治疗组的RFBF已恢复至对照水平。
皮肤温度无一致变化。
重度外周血管疾病患者均不应使用普萘洛尔和氧烯洛尔。
轻度外周血管疾病患者若有必要进行β肾上腺素受体阻滞,应优先使用氧烯洛尔而非普萘洛尔,但应谨慎处方。